NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1109 coverAutoimmunity, Part A Basic Principles and New Diagnostic Tools Volume 1109 published September 2007
Ann. N.Y. Acad. Sci. 1109: 185–192 (2007). doi: 10.1196/annals.1398.022
Copyright © 2007 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by WEITZEN, R.
Articles by ZIMLICHMAN, E.
Search for Related Content
PubMed
PubMed Citation
Articles by WEITZEN, R.
Articles by ZIMLICHMAN, E.

Part II. New Tools in Diagnosis

Diagnosing Diseases by Measurement of Electrical Skin Impedance

A Novel Technique

RONY WEITZENa, NAVA EPSTEINa, YEHUDA SHOENFELDb AND EYAL ZIMLICHMANb

a Oncology Institute, Sheba Medical Center, Tel-Hashomer, Israel b Internal Medicine B, Sheba Medical Center, Tel-Hashomer and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Key Words: skin impedance • screening • diagnostic tool • cancer • neuroreflexology

Address for correspondence: Eyal Zimlichman, M.D., Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer 52621, Israel. Voice: +972-3-5302661; fax: +972-3-5352855.  zimliche{at}post.tau.ac.il

Recently, we have seen the development of diagnostic tools based on the rationale that the measurement of electrical impedance of specific dermal zones might reflect the occurrence of pathological states in corresponding internal organs. Studies published lately have shown the diagnostic potential of this technique. We set out to evaluate the accuracy of this tool in diagnosing cancer. Our study group was composed of cancer patients visiting the Oncology clinic for a routine follow-up. All patients underwent conventional medical history and physical examination by a physician. We evaluated a device manufactured by Medex Screen Ltd. The device analysis was carried out by a physician who was blinded to the previous diagnosis. A third researcher compared the "conventional" diagnosis with the Medex device output using standard statistical analysis. Overall, 125 cancer patients were included in the study. When comparing Medex Screen diagnostic technique with the conventional methods of diagnosis for the various disorders we found a sensitivity of 76.2%, 78.7%, and 92.9% and a specificity of 95.0%, 90.7%, and 90.4% for lung, breast, and prostate cancer, respectively. Existence of metastatic disease or specific treatment did not affect the diagnostic properties of the described device. Although the exact mechanism is not entirely clear, measurement of electrical impedance of dermal–visceral zones has the potential to serve as a diagnostic and perhaps a screening tool for neoplastic pathologies. Further research should be conducted to create more evidence to support or dispute the use of this technique as a reliable diagnostic tool.






footerLeft footerRight